Astellas and Pfizer Inc. (collectively, the Companies) are committed to supporting high quality, evidence-based independent medical education (IME) that seeks to improve the overall safety and quality of patient care and treatment. The intent of this Call for Grant Applications (CGA) is to seek applications for independent Continuing Medical Education / Continuing Education (CME/CE) designed to close knowledge gaps identified in the public healthcare landscape, drive measurable improvements in knowledge, competence and performance of healthcare professionals, and advance patient health outcomes. “Independent” means that the projects funded are the full responsibility of the recipient organization. The Companies shall have no influence over any aspect of the supported projects and only ask for status updates, quarterly interim and final outcomes reports including a description of the overall impact of the project.
Application Deadline: December 24, 2024
Geographic Scope: Global - priority target audience is outside of the United States. At a minimum, proposals must have multi-country/regional reach.
Eligible applicants include Global Medical Education Providers with experience in executing IME with the capability of multiple language translations and global distribution channels. Collaborations between organizations and within institutions are acceptable. Please note all partners must have a relevant role and the requesting Organization must lead the project.
For all US-based organizations only, the accrediting organization must be the primary requestor on the grant application.
Each Individual event/activity request will be reviewed. The total budget for this CGA is $700,000 which is intended to support multiple activities and/or grants. Applicants must complete all budget fields in the system. Budget breakdown must include separate costs for language translations.